Processa Pharmaceuticals, Inc. (PCSA)

Data as of Aug 11, 2026, from SEC Form 4 filings.

XNASPHARMACEUTICAL PREPARATIONSNo open-market insider trades (90d)Watch PCSA

See up to 3 months of PCSA. The 7-day demo opens the 1M and 3M ranges and puts PCSA on your watchlist.

Latest PCSA insider trades

Wendy Guy - Officer
Open-market purchase$5K
Jun 30, 2026
Patrick Lin - Officer
Open-market purchase

About Processa Pharmaceuticals, Inc. (PCSA)

Processa Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on utilizing its regulatory science approach in the development of Next Generation Chemotherapy (NGC) oncology drug products. The company's strategic prioritization is to advance its pipeline of NGC proprietary small-molecule oncology drugs. The NGC products are new chemical entities, but the company works by changing the metabolism, distribution, and/or elimination of already FDA-approved cancer drugs or their active metabolites while maintaining the mechanism of how the drug kills cancer cells. The four NGC treatments in its pipeline are PCS6422 (also referred to as NGC-Cap), PCS11T, also referred to as NGC-Iri, is an analog of SN38, and PCS11T, PCS12852, and PCS499.

Headquarters: VERO BEACH, FL
Employees: 12
Listed: 2013
Exchange: XNAS
Sector: Health Care

https://www.processapharmaceuticals.com SEC filings for PCSA on EDGAR

PCSA Form 4 activity by transaction type, last 90 days

Form 4 transaction type	Transactions	Shares	Total value
Grant or award	10	285,011
Option exercise	2	3,200

Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.

PCSA insider transactions (Form 4)

81 Form 4 filings on record, the earliest from Jul 24, 2025, newest first. Filing history page 1 of 3.

Date	Insider	Transaction	Security	Shares	Price	Value
Aug 8, 2026	George K. Ng - Officer	Option exercise	Common Stock	1,600	-^{footnote F1}	-
Aug 8, 2026	George K. Ng - Officer	Option exercise	Restricted Stock	1,600	$0.00	-
Footnote F1 (price): Distribution of time-based service award.
Jul 28, 2026	Sheila Gujrathi - Director	Grant or award	Series A Preferred Stock	70,812	-^{footnote F2,F3}	-
Jul 28, 2026	Sheila Gujrathi - Director	Grant or award	Series A Preferred Stock	12,311	-^{footnote F2,F3}	-
Footnote F2 (price): Received in exchange for shares of common stock of Vidya Therapeutics, Inc. ("Vidya") pursuant to an Agreement and Plan of Merger, dated July 28, 2026 (the "Merger Agreement"), by and among the Company, Vidya, Venus Merger Sub I, Inc., a Delaware corporation and a wholly owned… Full note on SEC EDGAR Footnote F3 (price): Under the terms of the Merger Agreement, on July 28, 2026, Merger Sub I merged with and into Vidya, with Vidya surviving the first merger as a wholly owned subsidiary of the Company, and immediately following the first merger, Vidya merged with and into Merger Sub II, with… Full note on SEC EDGAR
Jul 26, 2026	Justin W. Yorke - Director	Grant or award	Restricted Stock Units	33,500^{footnote F1}	$0.00	-
Footnote F1 (shares): Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock. These RSUs vested upon grant, but will not be distributed until the earlier of: (i) their termination; (ii) six month anniversary of the grant date; (iii) change of… Full note on SEC EDGAR
Jul 26, 2026	Russell Skibsted - Officer	Grant or award	Restricted Stock Units	11,883^{footnote F1}	$0.00	-
Footnote F1 (shares): Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock. These RSUs vested upon grant, but will not be distributed until the earlier of: (i) their termination; (ii) six month anniversary of the grant date; (iii) change of… Full note on SEC EDGAR
Jul 26, 2026	Geraldine Pannu - Director	Grant or award	Restricted Stock Units	33,500^{footnote F1}	$0.00	-
Footnote F1 (shares): Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock. These RSUs vested upon grant, but will not be distributed until the earlier of: (i) their termination; (ii) six month anniversary of the grant date; (iii) change of… Full note on SEC EDGAR
Jul 26, 2026	George K. Ng - Officer	Grant or award	Restricted Stock Units	9,384^{footnote F1}	$0.00	-
Footnote F1 (shares): Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock. These RSUs vested upon grant, but will not be distributed until the earlier of: (i) their termination; (ii) six month anniversary of the grant date; (iii) change of… Full note on SEC EDGAR
Jul 26, 2026	James R. Neal - Director	Grant or award	Restricted Stock Units	62,221^{footnote F1}	$0.00	-
Footnote F1 (shares): Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock. These RSUs vested upon grant, but will not be distributed until the earlier of: (i) their termination; (ii) six month anniversary of the grant date; (iii) change of… Full note on SEC EDGAR
Jul 26, 2026	Patrick Lin - Officer	Grant or award	Restricted Stock Units	8,450^{footnote F1}	$0.00	-
Footnote F1 (shares): Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock. These RSUs vested upon grant, but will not be distributed until the earlier of: (i) their termination; (ii) six month anniversary of the grant date; (iii) change of… Full note on SEC EDGAR
Jul 26, 2026	Wendy Guy - Officer	Grant or award	Restricted Stock Units	9,450^{footnote F1}	$0.00	-
Footnote F1 (shares): Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock. These RSUs vested upon grant, but will not be distributed until the earlier of: (i) their termination; (ii) six month anniversary of the grant date; (iii) change of… Full note on SEC EDGAR
Jul 26, 2026	Khoso Baluch - Director	Grant or award	Restricted Stock Units	33,500^{footnote F1}	$0.00	-
Footnote F1 (shares): Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock. These RSUs vested upon grant, but will not be distributed until the earlier of: (i) their termination; (ii) six month anniversary of the grant date; (iii) change of… Full note on SEC EDGAR
Jun 30, 2026	Wendy Guy - Officer	Open-market purchase	Common Stock	2,436	$1.93	$5K
Jun 30, 2026	Patrick Lin - Officer	Open-market purchase	Common Stock	2,106	$1.93	$4K
Jul 1, 2026	George K. Ng - Officer	Open-market purchase	Common Stock	3,057	$1.93	$6K
Jun 30, 2026	Russell Skibsted - Officer	Open-market purchase	Common Stock	3,277	$1.93	$6K
Jun 30, 2026	David Young - Officer	Open-market purchase	Common Stock	2,531	$1.93	$5K
Jun 26, 2026	Justin W. Yorke	Option exercise	Restricted Stock	203	$0.00	-
Jun 26, 2026	Justin W. Yorke	Option exercise	Common Stock	203	-^{footnote F1}	-
Footnote F1 (price): Distribution of time-based service award.
Jun 26, 2026	Geraldine Pannu	Option exercise	Common Stock	203	-^{footnote F1}	-
Jun 26, 2026	Geraldine Pannu	Option exercise	Restricted Stock	203	$0.00	-
Footnote F1 (price): Distribution of time-based service award.
Jun 26, 2026	James R. Neal	Option exercise	Restricted Stock	203	$0.00	-
Jun 26, 2026	James R. Neal	Option exercise	Common Stock	203	-^{footnote F1}	-
Footnote F1 (price): Distribution of time-based service award.
Jun 26, 2026	Khoso Baluch	Option exercise	Restricted Stock	203	$0.00	-
Jun 26, 2026	Khoso Baluch	Option exercise	Common Stock	203	-^{footnote F1}	-
Footnote F1 (price): Distribution of time-based service award.
Jun 15, 2026	David Young - Officer	Open-market purchase	Common Stock	2,067	$2.22	$5K
Jun 15, 2026	Russell Skibsted - Officer	Open-market purchase	Common Stock	2,654	$2.22	$6K
Jun 15, 2026	George K. Ng - Officer	Open-market purchase	Common Stock	2,465	$2.22	$5K
Jun 15, 2026	Patrick Lin - Officer	Open-market purchase	Common Stock	1,831	$2.22	$4K
Jun 15, 2026	Wendy Guy - Officer	Open-market purchase	Common Stock	2,118	$2.22	$5K
May 29, 2026	David Young - Officer	Open-market purchase	Common Stock	1,786	$2.57	$5K
May 29, 2026	Russell Skibsted - Officer	Open-market purchase	Common Stock	2,292	$2.57	$6K
May 29, 2026	George K. Ng - Officer	Open-market purchase	Common Stock	2,129	$2.57	$5K
May 29, 2026	Patrick Lin - Officer	Open-market purchase	Common Stock	1,582	$2.57	$4K
May 29, 2026	Wendy Guy - Officer	Open-market purchase	Common Stock	1,829	$2.57	$5K
May 15, 2026	David Young - Officer	Open-market purchase	Common Stock	1,545	$2.97	$5K

Recent PCSA Form 8-K filings

Read PCSA company news

Oct 5, 2026Item 8.01, 9.01

Read the filing on SEC EDGAR

Aug 4, 2026Item 5.02, 5.07, 9.01

Read the filing on SEC EDGAR

Jul 29, 2026Item 1.01, 1.02, 2.01, 3.02, 5.02, 5.03, 7.01, 9.01

Read the filing on SEC EDGAR

Apr 30, 2026Item 5.02, 9.01

PCSA insider trading FAQ

What is the latest insider trade for PCSA?

Processa Pharmaceuticals, Inc. (PCSA) had 10 insider filings in the last 90 days, with the most recent on 2026-08-11. The full record for PCSA runs to 81 Form 4 filings, the earliest from 2025-07-24. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.

How many insiders are buying PCSA stock?

No insider purchases of PCSA were filed in the last 90 days. 42 purchases are on record for this company.

How many insiders are selling PCSA stock?

No insider sales of PCSA were filed in the last 90 days.

Where can I see PCSA SEC filings (Form 4, 10-K, 10-Q, 8-K)?

This page collects PCSA Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.

More Health Care companies with insider activity

Recent insider filings

The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.

Aug 11, 2026 - George K. Ng view on EDGAR
Jul 31, 2026 - Sheila Gujrathi view on EDGAR
Jul 29, 2026 - Justin W. Yorke view on EDGAR
Jul 29, 2026 - Russell Skibsted view on EDGAR
Jul 29, 2026 - Geraldine Pannu view on EDGAR
Jul 29, 2026 - George K. Ng view on EDGAR
Jul 29, 2026 - James R. Neal view on EDGAR
Jul 29, 2026 - Patrick Lin view on EDGAR
Jul 29, 2026 - Wendy Guy view on EDGAR

Related companies with recent insider activity

Learn more

What the Form 4 transaction codes mean: Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
Insider activity in Health Care: Where PCSA's peers are being bought and sold.
Every recent Form 4: The market-wide feed, updated as filings arrive from SEC EDGAR.

Follow PCSA with a 7-day demo

PCSA on your watchlist
Every PCSA Form 4 filing on record
Up to 3 months of PCSA price history
The daily trading plan of ranked insider buys, on a delay, with the plan archive

Start 7-day demoCard required. Your card is never charged for the demo.

Form 4 transaction type

Transactions

Total value

Grant or award

285,011

Option exercise

3,200

Date

Insider

Transaction

Security

Price

Value

Aug 8, 2026

George K. Ng - Officer

Option exercise

Common Stock

1,600

-^{footnote F1}

Aug 8, 2026

George K. Ng - Officer

Option exercise

Restricted Stock

1,600

$0.00

Footnote F1 (price): Distribution of time-based service award.

Jul 28, 2026

Sheila Gujrathi - Director

Grant or award

Series A Preferred Stock

70,812

-^{footnote F2,F3}

Jul 28, 2026

Sheila Gujrathi - Director

Grant or award

Series A Preferred Stock

12,311

-^{footnote F2,F3}

Footnote F2 (price): Received in exchange for shares of common stock of Vidya Therapeutics, Inc. ("Vidya") pursuant to an Agreement and Plan of Merger, dated July 28, 2026 (the "Merger Agreement"), by and among the Company, Vidya, Venus Merger Sub I, Inc., a Delaware corporation and a wholly owned… Full note on SEC EDGAR
Footnote F3 (price): Under the terms of the Merger Agreement, on July 28, 2026, Merger Sub I merged with and into Vidya, with Vidya surviving the first merger as a wholly owned subsidiary of the Company, and immediately following the first merger, Vidya merged with and into Merger Sub II, with… Full note on SEC EDGAR

Jul 26, 2026

Justin W. Yorke - Director

Grant or award

Restricted Stock Units

33,500^{footnote F1}

$0.00

Footnote F1 (shares): Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock. These RSUs vested upon grant, but will not be distributed until the earlier of: (i) their termination; (ii) six month anniversary of the grant date; (iii) change of… Full note on SEC EDGAR

Jul 26, 2026

Russell Skibsted - Officer

Grant or award

Restricted Stock Units

11,883^{footnote F1}

$0.00

Footnote F1 (shares): Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock. These RSUs vested upon grant, but will not be distributed until the earlier of: (i) their termination; (ii) six month anniversary of the grant date; (iii) change of… Full note on SEC EDGAR

Jul 26, 2026

Geraldine Pannu - Director

Grant or award

Restricted Stock Units

33,500^{footnote F1}

$0.00

Footnote F1 (shares): Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock. These RSUs vested upon grant, but will not be distributed until the earlier of: (i) their termination; (ii) six month anniversary of the grant date; (iii) change of… Full note on SEC EDGAR

Jul 26, 2026

George K. Ng - Officer

Grant or award

Restricted Stock Units

9,384^{footnote F1}

$0.00

Footnote F1 (shares): Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock. These RSUs vested upon grant, but will not be distributed until the earlier of: (i) their termination; (ii) six month anniversary of the grant date; (iii) change of… Full note on SEC EDGAR

Jul 26, 2026

James R. Neal - Director

Grant or award

Restricted Stock Units

62,221^{footnote F1}

$0.00

Footnote F1 (shares): Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock. These RSUs vested upon grant, but will not be distributed until the earlier of: (i) their termination; (ii) six month anniversary of the grant date; (iii) change of… Full note on SEC EDGAR

Jul 26, 2026

Patrick Lin - Officer

Grant or award

Restricted Stock Units

8,450^{footnote F1}

$0.00

Footnote F1 (shares): Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock. These RSUs vested upon grant, but will not be distributed until the earlier of: (i) their termination; (ii) six month anniversary of the grant date; (iii) change of… Full note on SEC EDGAR

Jul 26, 2026

Wendy Guy - Officer

Grant or award

Restricted Stock Units

9,450^{footnote F1}

$0.00

Footnote F1 (shares): Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock. These RSUs vested upon grant, but will not be distributed until the earlier of: (i) their termination; (ii) six month anniversary of the grant date; (iii) change of… Full note on SEC EDGAR

Jul 26, 2026

Khoso Baluch - Director

Grant or award

Restricted Stock Units

33,500^{footnote F1}

$0.00

Footnote F1 (shares): Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock. These RSUs vested upon grant, but will not be distributed until the earlier of: (i) their termination; (ii) six month anniversary of the grant date; (iii) change of… Full note on SEC EDGAR

Jun 30, 2026

Wendy Guy - Officer

Open-market purchase

Common Stock

2,436

$1.93

$5K

Jun 30, 2026

Patrick Lin - Officer

Open-market purchase

Common Stock

2,106

$1.93

$4K

Jul 1, 2026

George K. Ng - Officer

Open-market purchase

Common Stock

3,057

$1.93

$6K

Jun 30, 2026

Russell Skibsted - Officer

Open-market purchase

Common Stock

3,277

$1.93

$6K

Jun 30, 2026

David Young - Officer

Open-market purchase

Common Stock

2,531

$1.93

$5K

Jun 26, 2026

Justin W. Yorke

Option exercise

Restricted Stock

203

$0.00

Jun 26, 2026

Justin W. Yorke

Option exercise

Common Stock

203

-^{footnote F1}

Footnote F1 (price): Distribution of time-based service award.

Jun 26, 2026

Geraldine Pannu

Option exercise

Common Stock

203

-^{footnote F1}

Jun 26, 2026

Geraldine Pannu

Option exercise

Restricted Stock

203

$0.00

Footnote F1 (price): Distribution of time-based service award.

Jun 26, 2026

James R. Neal

Option exercise

Restricted Stock

203

$0.00

Jun 26, 2026

James R. Neal

Option exercise

Common Stock

203

-^{footnote F1}

Footnote F1 (price): Distribution of time-based service award.

Jun 26, 2026

Khoso Baluch

Option exercise

Restricted Stock

203

$0.00

Jun 26, 2026

Khoso Baluch

Option exercise

Common Stock

203

-^{footnote F1}

Footnote F1 (price): Distribution of time-based service award.

Jun 15, 2026

David Young - Officer

Open-market purchase

Common Stock

2,067

$2.22

$5K

Jun 15, 2026

Russell Skibsted - Officer

Open-market purchase

Common Stock

2,654

$2.22

$6K

Jun 15, 2026

George K. Ng - Officer

Open-market purchase

Common Stock

2,465

$2.22

$5K

Jun 15, 2026

Patrick Lin - Officer

Open-market purchase

Common Stock

1,831

$2.22

$4K

Jun 15, 2026

Wendy Guy - Officer

Open-market purchase

Common Stock

2,118

$2.22

$5K

May 29, 2026

David Young - Officer

Open-market purchase

Common Stock

1,786

$2.57

$5K

May 29, 2026

Russell Skibsted - Officer

Open-market purchase

Common Stock

2,292

$2.57

$6K

May 29, 2026

George K. Ng - Officer

Open-market purchase

Common Stock

2,129

$2.57

$5K

May 29, 2026

Patrick Lin - Officer

Open-market purchase

Common Stock

1,582

$2.57

$4K

May 29, 2026

Wendy Guy - Officer

Open-market purchase

Common Stock

1,829

$2.57

$5K

May 15, 2026

David Young - Officer

Open-market purchase

Common Stock

1,545

$2.97

$5K